Global Health Limited (NSE:MEDANTA)
India · Delayed Price · Currency is INR 1,405.00
-11.40 (-0.80%)
Jul 31, 2026, 3:30 PM IST
Global Health Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 46,835 | 44,103 | 36,923 | 32,751 | 27,099 | 21,725 |
Revenue Growth | 21.27% | 19.44% | 12.74% | 20.86% | 24.74% | 49.63% |
Gross Profit Gross Profit Growth | 24,724 | 23,174 | 19,152 | 17,167 | 13,755 | 10,057 |
Operating Income Operating Income Growth | 7,324 | 6,966 | 6,829 | 6,283 | 4,844 | 3,346 |
Net Income Net Income Growth | 5,562 | 5,565 | 4,814 | 4,782 | 3,261 | 1,962 |
Earnings Per Share EPS Growth | 21.20 | 20.66 | 17.92 | 17.80 | 12.57 | 7.77 |
EPS Growth | 6.71% | 15.29% | 0.67% | 41.61% | 61.78% | 581.58% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 11,302 | 11,302 | 10,507 | 11,561 | 12,604 | 4,878 |
Total Debt Total Debt Growth | 11,900 | 11,900 | 7,177 | 8,019 | 11,220 | 11,089 |
Net Cash (Debt) Net Cash Growth | -598.18 | -598.18 | 3,330 | 3,543 | 1,384 | -6,211 |
Net Cash Growth | - | - | -6.00% | 155.89% | - | - |
Net Cash Per Share Net Cash Per Share Growth | -2.28 | -2.22 | 12.40 | 13.19 | 5.34 | -24.61 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | 7,144 | 6,238 | 6,121 | 6,445 | 3,113 |
Capital Expenditures CapEx Growth | - | -8,382 | -5,165 | -2,786 | -2,360 | -2,745 |
Free Cash Flow Free Cash Flow Growth | - | -1,238 | 1,072 | 3,335 | 4,085 | 367.87 |
Free Cash Flow Growth | - | - | -67.85% | -18.37% | 1010.54% | -61.69% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 52.79% | 52.54% | 51.87% | 52.42% | 50.76% | 46.29% |
Operating Margin | 15.64% | 15.79% | 18.50% | 19.18% | 17.87% | 15.40% |
Pretax Margin | 15.38% | 16.21% | 17.53% | 19.15% | 16.58% | 12.91% |
Profit Margin | 11.88% | 12.62% | 13.04% | 14.60% | 12.03% | 9.03% |
FCF Margin | - | -2.81% | 2.90% | 10.18% | 15.08% | 1.69% |
| Fiscal Year | Current | FY 2026 | FY 2025 |
|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 |
Dividend Per Share Dividend Per Share Growth | 0.500 | 0.500 | 0.500 |
Dividend Per Share Growth | 0% | 0% | - |
Dividend Yield | 0.04% | 0.05% | 0.04% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 66.29 | 46.43 | 66.85 | 74.18 | 43.34 | - |
Forward PE | 50.52 | 39.25 | 52.37 | 59.16 | 39.58 | - |
P/FCF Ratio | - | - | 300.19 | 106.37 | 34.59 | - |
PS Ratio | 8.07 | 5.86 | 8.72 | 10.83 | 5.22 | - |